An Eli Lilly and Company pharmaceutical manufacturing plant at 50 ImClone Drive in Branchburg, NJ., in this file photo. Mike Segar/ReutersPharmaceutical giant Eli Lilly is warning patients about the potential danger of taking compounded tirzepatide, marketed as Zebound and Mounjaro, mixed with vitamin B12.After testing copycat drug products containing the tizepatide and B12 combination, the drug manufacturer found “significant levels of impurity” resulting from a chemical reaction between the two substances.
22.5
C
Ottawa
Wednesday, June 17, 2026
The Alliance Press is the world leader in online chained news and information and seeks to inform, engage and empower the world. We expose the information that wasn't known before or current events broadcast over the radio, television, online or in print media. Our content is now available through your mobile phone. No matter where your on-the-go lifestyle takes you, TAP brings the news directly to you.
More from CN
Contact
© The Alliance Media Group design by CODEUS